TY - JOUR
T1 - The determinants of response to diltiazem in hypertension
AU - Shepherd, Alexander M.M.
AU - Leforce, Carla
AU - Park, Glen D.
AU - Hoop, Robert S.
AU - Weir, Scott
PY - 1991/9
Y1 - 1991/9
N2 - We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow‐release diltiazem in an unblinded study after a placebo run‐in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear step wise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension. Clinical Pharmacology and Therapeutics (1991) 50, 338–349; doi:
AB - We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow‐release diltiazem in an unblinded study after a placebo run‐in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear step wise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension. Clinical Pharmacology and Therapeutics (1991) 50, 338–349; doi:
UR - http://www.scopus.com/inward/record.url?scp=0025940818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025940818&partnerID=8YFLogxK
U2 - 10.1038/clpt.1991.145
DO - 10.1038/clpt.1991.145
M3 - Article
C2 - 1914368
AN - SCOPUS:0025940818
VL - 50
SP - 338
EP - 349
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 3
ER -